講演・口頭発表等 - 田中　一

1. Hajime Tanaka. The Emergent Role of Theranostics in Renal Cell Carcinoma. UAA annual congress 2024 2024.09.05

2. Yuki Nakamura, Yudai Ishikawa, Shunya Matsumoto, Riko Ikeda, Kasumi Yoshitomi, Masaki Kobayashi, Motohiro Fujiwara, Bo Fan, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Can photodynamic diagnosis-guided biopsy replace bladder mapping biopsy?. AUA annual meeting 2024 2024.05.06

3. Keita Izumi, Hajime Tanaka, Masataka Yano, Ryoji Takazawa, Akira Noro, Tetsuro Tsukamoto, Junji Yonese, Tesuo Okuno, Yasuyuki Sakai, Fumitaka Koga, Yukio Kageyama, Kazutaka Saito, Yasuhisa Fujii. Real-word outcomes of maintenance chemotherapy versus avelumab therapy after first-line induction chemotherapy for advanced urothelial carcinoma: YUSHIMA study. AUA annual meeting 2024 2024.05.05

4. Rikuto Yasujima, Hajime Tanaka, Junichi Tsuchiya, Akira Hasegawa, Hiroki Tanaka, Tomoki Kimura, Kotaro Suzuki, Tsubasa Ito, Riko Ikeda, Shunya Matsumoto, Kasumi Yoshitomi,Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Wei Chen, Fan Bo, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Yasuhisa Fujii. Exploring the Role of FDG PET/CT in Predicting Pembrolizumab Response for Metastatic Urothelial Carcinoma. "AUA annual meeting 2024 2024.05.05

5. Motohiro Fujiwara, Daisuke Hirahara, Tatsunori Saho, Eichi Takaya, Akira Hasegawa, Tomoki Kimura, Kotaro Suzuki, Hiroki Tanaka, Tsubasa Ito, Rikuto Yasujima, Riko Ikeda, Shunya Matsumoto, Kasumi Yoshitomi, Masaki Kobayashi, Yuki Nakamura, Wei Chen, Bo Fan, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Delta-radiomics analysis in comparison to radiomics analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma. AUA annual meeting 2024 2024.05.04

6. Tanaka H, Fujiwara M, Hasegawa A, Tanaka H, Suzuki K, Kimura T, Yasujima R, Ito T, Ikeda R, Matsumoto S, Yoshitomi K, Kobayashi M, Nakamura Y, Fan B, Chen W, Ishikawa Y, Fukuda S, Waseda Y, Yoshida S, Yoshimura R, Kihara K, Fujii Y.. Long-term oncologic outcomes of tetramodal bladder-preservation therapy incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymphnode dissection for muscle-invasive bladder cancer. AUA annual meeting 2024 2024.05.04

7. 田中　一、藤井　靖久. Management and treatment outcomes for intravesical recurrence after bladder preservation therapy for muscle-invasive bladder cancer. 2024.04.27

8. 田中　一、藤原　基裕、小林　正貴、中村　祐基、Fan Bo、石川　雄大、福田　翔平、 早稲田　悠馬、吉田　宗一郎 、吉村　亮一 、木原　和徳、藤井　靖久. Long-term oncologic outcomes of tetramodal bladder-preservation therapy for muscle-invasive bladder cancer. 第111回日本泌尿器科学会総会 2024.04.25

9. Horie T, Fujiwara M, Hasegawa A, Kimura T, Suzuki K, Tanaka H, Ito T, Yasujima R, Ikeda R, Matsumoto S,Yoshitomi K, Kobayashi M, Nakamura Y, Chen W, Fan B, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Radiomics analysis using non-contrast computed tomography for predicting HDU admission in patients with acute pyelonephritis. EAU annual meeting 2024 2024.04.08

10. Tanaka H, Fujiwara M, Hasegawa A, Tanaka H, Suzuki K, Kimura T, Yasujima R, Ito T, Ikeda R, Matsumoto S, Yoshitomi K, Kobayashi M, Nakamura Y, Fan B, Chen W, Ishikawa Y, Fukuda S, Waseda Y, Yoshida S, Yoshimura R, Kihara K, Fujii Y.. Tetramodal bladder-preservation therapy incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymphnode dissection for muscle-invasive bladder cancer: long-term oncologic outcomes of 201 patients. EAU annual congress 2024 2024.04.08

11. Kenji Tanabe, Shuichiro Kobayashi, Katsyshi Nagashima, Junji Yonese, Yukihiro Ohtsuka, Tetsuo Okuno, Ryoji Takazawa, Akira Noro, Masataka, Yano, Tetsuro Tsukamoto, Kazutaka Saito, Yasuyuki Sakai, Fumitaka Koga, Yukio Kageyama, Hajime Tanaka, Soichiro Yoshida and Yasuhisa Fujii. The Gustave Roussy Immune Score Predicts Survival Outcome of Patients with Metastatic Urothelial Carcinoma Treated with Pembrolizumab: YUSHIMA study. EAU annual congress 2024 2024.04.07

12. "Tomoki Kimura, Motohiro Fujiwara, Shunya Matsumoto, Kasumi Yoshitomi, Masaki Kobayashi, Bo Fan, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Ryoji Takazawa, Yasuyuki Sakai, Fumitaka Koga, Kazutaka Saito, Masataka Yano, Tetsuro Tsukamoto, Tetsuo Okuno, Yukio Kageyama, Yukihiro Otsuka, Katsushi Nagahama, Yasuhisa Fuji". "Real-world outcomes of first-line systematic treatment in advanced Upper-Urinary Tract Urothelial Carcinoma patients with renal impairment : YUSHIMA-04 study". EAU annual congress 2024 2024.04.05

13. Motohiro Fujiwara, Daisuke Hirahara, Tatsunori Saho, Eichi Takaya, Akira Hasegawa,Tomoki Kimura, Kotaro Suzuki, Hiroki Tanaka, Tsubasa Ito, Rikuto Yasujima, Riko Ikeda,Shunya Matsumoto, Kasumi Yoshitomi, Masaki Kobayashi, Yuki Nakamura, Wei Chen, Bo Fan, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Delta-radiomics analysis in comparison to radiomics analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma. EAU annual meeting 2024 2024.04.05

14. Tanaka H, Fujii Y.. Presurgical systemic therapy and subsequent cytoreductive nephrectomy (CN). EAU annual congress 2024 2024.04.05

15. Hajime Tanaka. Presurgical Immune Checkpoint Inhibitors in Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus: Yes or No?. Advancements in Urology: An AUA/JUA Symposium 2024.03.09

16. 田中 一, 藤原 基裕, 吉富 香澄, 小林 正貴, 中村 祐基, 范 博, 石川 雄大, 福田 翔平, 早稲田 悠馬, 吉田 宗一郎, 吉村 亮一, 藤井 靖久. 筋層浸潤性膀胱癌に対する膀胱温存療法の至適対象の探索　膀胱切除検体を用いた検討. 日本癌治療学会学術集会抄録集 2023.10.01

17. Tanaka Hajime. Renal parenchymal infiltration or micronodular spread in clear cell renal cell carcinoma: prognostic impact and genomic backgrounds. the 110th Annual Meeting of the Japanese Urological Association 2023.04.20

18. 相馬 貴彦, 吉田 宗一郎, 吉富 香澄, 小林 正貴, 范 博, 藤原 基裕, 中村 祐基, 石川 雄大, 福田 翔平, 早稲田 悠馬, 田中 一, 横山 みなと, 藤井 靖久. CRPCの予後予測因子としてのADC値を考慮した腫瘍体積の検討(Tumor diffusion volume according to apparent diffusion coefficient values as a prognostic factor for castration-resistant prostate cancer). 日本泌尿器科学会総会 2023.04.01

19. 会田 祐介, 石川 雄大, 田中 一, 吉富 香澄, 相馬 貴彦, 小林 正貴, 范 博, 藤原 基裕, 中村 祐基, 早稲田 悠馬, 吉田 宗一郎, 横山 みなと, 藤井 靖久. 当院における転移性尿路上皮癌に対するアベルマブを用いた維持療法の初期使用経験(Initial experience of maintenance avelumab for metastatic urothelial carcinoma). 日本泌尿器科学会総会 2023.04.01

20. 金子 香澄, 田中 一, 藤原 基裕, 中村 祐基, 石川 雄大, 福田 翔平, 早稲田 悠馬, 吉田 宗一郎, 横山 みなと, 藤井 靖久. 実臨床での淡明細胞型腎細胞癌患者におけるKEYNOTE-564試験リスクカテゴリーの検証(Evaluation of the risk categories in KEYNOTE-564 trial in patients with clear cell renal cell carcinoma treated in real-world practice). 日本泌尿器科学会総会 2023.04.01